Practical implications of the revised guidelines for inpatient glycemic control

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 12, 2009, Pages 801-809

  Reider, Jodie ^a   Donihi, Amy ^b   Korytkowski, Mary T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Diabetes mellitus; Hospital; Hyperglycemia; Inpatients; Insulin

Indexed keywords

GLUCOSE; GUANOSINE TRIPHOSPHATE PYROPHOSPHOKINASE; INSULIN; METFORMIN; SULFONYLUREA;

CLINICAL PRACTICE; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DIET RESTRICTION; DRUG CONTRAINDICATION; DRUG HALF LIFE; DRUG USE; ENTERIC FEEDING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH STATUS; HEART INFARCTION; HEART SURGERY; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN INFUSION; INSULIN TREATMENT; PATIENT CARE; PATIENT SAFETY; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; VASCULAR SURGERY;

EID: 75649106501     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.847     Document Type: Review

References (81)

1. Moghissi ES, Korytkowski MT, DiNardo MM, et al. American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control. Diabetes Care. 2009; 32: 1119-1131.
2. Wexler DJ, Meigs JB, Cagliero E, et al. Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals. Diabetes Care. 2007; 30: 367-369.
3. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002; 87: 978-982.
4. Donihi AC, DiNardo MM, DeVita MA, Korytkowski MT. Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin. Quaf Saf Health Care. 2006; 15: 89-91.
5. Levetan CS, Passaro M, Jablonski K, et al. Unrecognized diabetes among hospitalized patients. Diabetes Care. 1998; 21: 246-249.
6. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001; 345: 1359-1367.
7. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med. 2003; 31: 359-366.
8. Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006; 34: 612-616.
9. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004; 79: 992-1000.
10. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003; 125: 1007-1021.
11. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004; 109: 1497-1502.
12. Bochicchio GV, Sung J, Joshi M, et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma. 2005; 58: 921-924.
13. Garber AJ, Moghissi ES, Bransome ED, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004; 10 Suppl 2: 4-9.
14. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006; 61: 284-289.
15. Cheung NW, Napier B, Zaccaria C, Fletcher JP. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care. 2005; 28: 2367-2371.
16. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009; 180: 821-827.
17. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2009; 300: 933-944.
18. Finfer S, Chittock DR, Su SY-S, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009; 360: 1283-1297.
19. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008; 358: 125-139.
20. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354: 449-461.
21. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004; 27: 553-591.
22. Stegenga ME, van der Crabben SN, Blumer RME, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood. 2008; 112: 82-89.
23. Ishihara M, Inoue I, Kawagoe T, et al. Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with a first anterior wall acute myocardial infarction. Am J Cardiol. 2003; 92: 288-291.
24. Van den Berghe G. Insulin therapy for the critically ill patient. Clin Cornerstone. 2003; 5: 56-63.
25. Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008; 36: 3190-3197.
26. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI Study Group. BMJ. 1997; 314: 1512-1515.
27. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005; 26: 650-661.
28. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005; 293: 437-446.
29. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004; 10 Suppl 2: 21-33.
30. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997; 63: 356-361.
31. van der Crabben SN, Blumer RM, Stegenga ME, et al. Early endotoxemia increases peripheral and hepatic insulin sensitivity in healthy humans. J Clin Endocrinol Metab. 2009; 94: 463-468.
32. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009; 35: 1738-1748.
33. Inzucchi SE, Siegel MD. Glucose control in the ICU - how tight is too tight? N Engl J Med. 2009; 60: 1346-1349.
34. Van den Berghe GS, Schetz M, Vlasselaers D, et al. Intensive insulin therapy in critically in patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab. 2009; 94: 3163-3170.
35. Kelly JL, Hirsch IB, Furnary AP. Implementing an intravenous insulin protocol in your practice: practical advice to overcome clinical, administrative, and financial barriers. Semin Thorac Cardiovasc Surg. 2006; 18: 346-358.
36. Schmeltz LR, DeSantis AJ, Thiyagarajan V, et al. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care. 2007; 30: 823-828.
37. Noschese M, Donihi AC, Koerbel G, et al. Effect of a Diabetes Order Set on glycaemic management and control in the hospital. Qual Saf Health Care. 2008; 17: 464-468.
38. Korytkowski M, Dinardo M, Donihi AC, et al. Evolution of a Diabetes Inpatient Safety Committee. Endocr Pract. 2006; 12 Suppl 3: 91-99.
39. Magee MF, Clement S. Subcutaneous insulin therapy in the hospital setting: issues, concerns, and implementation. Endocr Pract. 2004; 10 Suppl 2: 81-88.
40. Scott MG, Bruns DE, Boyd JC, Sacks DB. Tight glucose control in the intensive care unit: are glucose meters up to the task? Clin Chem. 2009; 55: 18-20.
41. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care. 2007; 30: 403-409.
42. McNeil BJ. Shattuck Lecture - hidden barriers to improvement in the quality of care. N Engl J Med. 2001; 345: 1612-1620.
43. Cook CB, Castro JC, Schmidt RE, et al. Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentum. J Hosp Med. 2007; 2: 203-211.
44. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004; 27: 461-467.
45. Metchick LN, Petit WA Jr, Inzucchi SE. Inpatient management of diabetes mellitus. Am J Med. 2002; 113: 317-323.
46. Nazer LH, Chow SL, Moghissi ES. Insulin infusion protocols for critically in patients: a highlight of differences and similarities. Endocr Pract 2007; 13: 137-146.
47. Blaha J, Kopecky P, Matias M, et al. Comparison of three protocols for tight glycemic control in cardiac surgery patients. Diabetes Care. 2009; 32: 757-761.
48. Wilson M, Weinreb J, Hoo GW. Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care. 2007; 30: 1005-1011.
49. Rea RS, Donihi AC, Bobeck M, et al. Implementing an intravenous insulin infusion protocol in the intensive care unit. Am J Health Syst Pharm. 2007; 64: 385-395.
50. Goldberg PA, Bozzo JE, Thomas PG, et al. "Glucometrics" - assessing the quality of inpatient glucose management Diabet Technol Ther. 2006; 8: 560-569.
51. Umpierrez GE, Hor T, Smiley D, et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedom plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab. 2009; 94: 564-569.
52. Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007; 30: 2181-2186.
53. Umpierrez G, Maynard G. Glycemic chaos (not glycemic control) still the rule for inpatient care: how do we stop the insanity? J Hosp Med. 2006; 1: 141-144.
54. Hirsch IB. Sliding scale insulin - time to stop sliding. JAMA. 2009; 301: 213-214.
55. Baldwin D, Villanueva G, McNutt R, Bhatnagar S. Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. Diabetes Care. 2005; 28: 1008-1011.
56. Korytkowski MT, Salata RJ, Koerbel GL, et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care. 2009; 32: 594-596.
57. Umpierrez GE. Basal versus sliding-scale regular insulin in hospitalized patients with hyperglycemia during enteral nutrition therapy. Diabetes Care. 2009; 32: 751-753.
58. Donihi A, Raval D, Saul M, et al. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006; 12: 358-362.
59. Schmeltz LR, DeSantis AJ, Schmidt K, et al. Conversion of intravenous insulin infusions to subcutaneousfy administered insulin glargine in patients with hyperglycemia. Endocr Pract. 2006; 12: 641-650.
60. Donihi A, Rea R, Mihalko M, Korytkowski M. Comparison of Different Methods of Transitioning MICU Patients from Intravenous to Subcutaneous Insulin. Diabetes. 2007; 57: A542.
61. Mathiesen ER, Christensen AB, Hellmuth E, et al. Insulin dose during glucocorticoid treatment for fetal lung maturation in diabetic pregnancy: [correction of an algorithm] Acta Obstet Gynecol Scand. 2002; 81: 835-839.
62. Nabhan FA. Hyperglycemia in the hospital setting. N Engl J Med. 2007; 356: 753.
63. Reider J, Lin H, DiNardo M, et al. Efficacy of a guideline for treatment of corticosteroid related hyperglycemia in the hospital. Diabetes. 2008; 57: A574.
64. Clore JN, Thurby-Hay L. Glucocorticoid-Induced Hyperglycemia. Endocr Pract. 2009; 15: 469-474.
65. Pancorbo-Hidalgo PL, Garcia-Fernandez FP, Ramirez-Perez C. Complications associated with enteral nutrition by nasogastric tube in an internal medicine unit. J Clin Nurs. 2001; 10: 482-490.
66. Noschese ML, DiNardo MM, Donihi AC, et al. Patient Outcomes After Implementation of a Protocol for Inpatient Insulin Pump Therapy. Endocr Pract. 2009; 15: 415-424.
67. Bailon RM, Partlow PB, Miller-Cage V, et al. Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients. Endocr Pract. 2009; 15: 24-29.
68. Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006; 355: 1903-1911.
69. Bodmer M, Meier C, Krahenbuhl S, et al. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care. 2008; 31: 2086-2091.
70. Gonzalez RR, Zweig S, Rao J, et al. Octreotide therapy for recurrent refractory hypoglycemia due to sulfonylurea in diabetes-related kidney failure. Endocr Pract. 2007; 13: 417-423.
71. Bolen S, Feldman L, Vassy J, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med. 2007; 147: 386-399.
72. Calabrese AT, Coley KC, DaPos SV, et al. Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. Arch Intern Med. 2002; 162: 434-437.
73. Dunham DP, Baker D. Use of an electronic medical record to detect patients at high risk of metformin-induced lactic acidosis. Am J Health Syst Pharm. 2006; 63: 657-660.
74. Krentz AJ, Patel MB, Bailey CJ. New drugs for type 2 diabetes mellitus: what is their place in therapy? Drugs. 2008; 68: 2131-2162.
75. Turchin A, Matheny ME, Shubina M, et al. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009; 32: 1153-1157.
76. Smith WD, Winterstein AG, Johns T, et al. Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health Syst Pharm. 2005; 62: 714-719.
77. Hellman R. A systems approach to reducing errors in insulin therapy in the inpatient setting. Endocr Pract. 2004; 10 Suppl 2: 100-108.
78. DiNardo M, Donihi A, DeVita M, et al. A nurse-directed protocol for recognition and treatment of hypoglycemia in hospitalized patients. Pract Diabetol. 2005; 22: 37-44.
79. DiNardo M, Korytkowski M, Calabrese A, et al. Introduction of an inpatient hypoglycemia treatment protocol: effect on nurses' confidence and knowledge. In: 62nd Scientific Meetings of the American Diabetes Association San Francisco, CA, American Diabetes Association, 2002, p. A212.
80. DiNardo M, Noschese M, Korytkowski M, Freeman S. The medical emergency team and rapid response system: finding, treating, and preventing hypoglycemia. Jt Comm J Dual Patient Saf. 2006; 32: 591-595.
81. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract 2006; 12: 458-468.